// App-Quantinova.ai

: Longitudinal change in hyperpolarised 129-xenon MR spectroscopy in interstitial lung disease

Researchers

Presenter

  • James Eaden

Principal Investigators

  • Paul Hughes

  • Guilhem Collier

  • Graham Norquay

  • Nicholas Weatherly

  • Matthew Austin

  • Laurie Smith

  • Jim Lithgow

  • Andrew Swift

  • Stephen Renshaw

  • Maya Buch

  • Colm Leonard

  • Sarah Skeoch

  • Nazia Chaudhuri

  • Geoff Parker

  • Stephen Bianchi

  • Jim Wild

Medical Centers

  • Academic Unit of Nephrology, Department of Infection, Immunity and Cardiovascular disease University of Sheffield Sheffield United Kingdom

  • Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom,

  • The University of Manchester NHS Foundation Trust, Manchester, United Kingdom

  • University of Manchester, Manchester, United Kingdom

  • Bioxydyn Limited, Manchester, United Kingdom

  • Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Extrinsic allergic alveolitis

  • Interstitial lung disease

  • Pulmonary alveolar proteinosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multicenteric

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved